Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Suzhong Haixin Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Suzhong Pharmaceutical Group, located in the China Medical City of Taizhou. The company is best known for its flagship product, the Huang Kui Capsule, which is a leading traditional Chinese medicine (TCM) treatment for chronic kidney diseases and proteinuria. Beyond TCM, Suzhong Haixin produces a variety of chemical drugs and injections targeting cardiovascular, respiratory, and digestive ailments. The company maintains high-standard GMP production lines and integrates research, development, and commercialization to serve the domestic Chinese market. It plays a significant role in the regional pharmaceutical industry as a key high-tech enterprise in Jiangsu province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Suzhong Haixin Pharmaceutical.